Noxopharm Ltd (NOX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 2.404x

Based on the latest financial reports, Noxopharm Ltd (NOX) has a cash flow conversion efficiency ratio of 2.404x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.71 Million ≈ $-1.92 Million USD) by net assets (AU$-1.13 Million ≈ $-797.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Noxopharm Ltd (NOX) liquidity interval to measure how many days the company can operate on defensive assets alone.

Noxopharm Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Noxopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Noxopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Noxopharm Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PIMS Inc. KQ:347770	0.014x
All In! Games S.A. WAR:ALG	0.149x
Pelikan International Corp KLSE:5231	-0.039x
RGT Bhd KLSE:9954	0.028x
PRI EKOPARK SA ZY -10 F:NPA	0.542x
Robot S.A. MC:RBT	0.077x
Dhunseri Tea & Industries Limited NSE:DTIL	0.040x
Ruchi Infrastructure Limited NSE:RUCHINFRA	0.089x

Annual Cash Flow Conversion Efficiency for Noxopharm Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Noxopharm Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see NOX market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$689.96K ≈ $488.19K	AU$-5.82 Million ≈ $-4.12 Million	-8.442x	-6679.01%
2024-06-30	AU$5.50 Million ≈ $3.89 Million	AU$-684.31K ≈ $-484.19K	-0.125x	+89.68%
2023-06-30	AU$9.07 Million ≈ $6.42 Million	AU$-10.95 Million ≈ $-7.75 Million	-1.206x	-111.87%
2022-06-30	AU$24.12 Million ≈ $17.06 Million	AU$-13.73 Million ≈ $-9.72 Million	-0.569x	-162.35%
2021-06-30	AU$40.78 Million ≈ $28.85 Million	AU$-8.85 Million ≈ $-6.26 Million	-0.217x	+74.91%
2020-06-30	AU$12.87 Million ≈ $9.11 Million	AU$-11.14 Million ≈ $-7.88 Million	-0.865x	-112.84%
2019-06-30	AU$-1.45 Million ≈ $-1.03 Million	AU$-9.78 Million ≈ $-6.92 Million	6.740x	+853.61%
2018-06-30	AU$10.15 Million ≈ $7.18 Million	AU$-9.08 Million ≈ $-6.42 Million	-0.894x	+24.37%
2017-06-30	AU$2.47 Million ≈ $1.75 Million	AU$-2.92 Million ≈ $-2.06 Million	-1.183x	-1179.11%
2016-06-30	AU$5.95 Million ≈ $4.21 Million	AU$-549.72K ≈ $-388.96K	-0.092x	--

About Noxopharm Ltd

AU:NOX Australia Biotechnology

Market Cap

$15.87 Million

AU$22.43 Million AUD

Market Cap Rank

#25836 Global

#1151 in Australia

Share Price

AU$0.07

Change (1 day)

-5.19%

52-Week Range

AU$0.04 - AU$0.13

All Time High

AU$1.58